As a result, many Face Works patients notice not only fat reduction but also a firmer, tighter appearance of the skin in treated areas
Patients who are already managing the once-weekly injection cadence of Semaglutide or Tirzepatide and do not want to add daily injections are not good candidates for GHK-Cu, not because of any contraindication, but because they wont maintain the protocol consistently enough to see results
The FDA has been attempting to ban NAC supplements, so they may be hard to acquire
If it persists, your doctor may recommend dietary changes or evaluating other causes
cAMP has both pro-apoptotic and anti-apoptotic action in a large number of different cells and even in the same cell
The FDA approval is for short-term use, but research and clinical practice support longer monitored use in many patients